RGEN 8-K 2026-11-06

REPLIGEN CORP (RGEN) 8-K dated 2026-11-06 — accession 0001628280-26-071650.

REPLIGEN CORP (RGEN) is a medical instruments & supplies company listed on NASDAQ.

REPLIGEN CORP filed a 8-K on 2026-11-06. Accession 0001628280-26-071650.

This 8-K covers: Material agreement (Item 1.01), New debt obligation (Item 2.03), Unregistered share sale (Item 3.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported RGEN revenue for 2025-12-31 was $738.3M. Net income was $48.9M. Revenue was up 16.4% from 2024-12-31 to 2025-12-31. RGEN currently screens at market cap $7.43B.

Not investment advice. The RGEN SEC hub lists recent forms. The stock page is the research view.